Searchable abstracts of presentations at key conferences in endocrinology

ea0090p386 | Endocrine-related Cancer | ECE2023

Elderly Male with Multiple Endocrine Neoplasia Type 2A: A Diagnostic Journey

Vrckovnik Rok , Kocjan Tomaž

Background: Multiple endocrine neoplasia type 2A (MEN2A) is a rare genetic tumor syndrome due to germline mutations of the RET proto-oncogene, which is characterized by medullary thyroid cancer (MTC), pheochromocytoma (PHEO), and primary hyperparathyroidism (PHPT). The age at onset, aggressiveness of MTC, and the penetrance of other components depend on the genotype. Early prophylactic thyroidectomy and life-long screening for PHEO from childhood are recommended in most cases....

ea0086p254 | Neuroendocrinology and Pituitary | SFEBES2022

Prevalence of cancer in a cohort of acromegaly patients

Trifanescu Raluca , Toma Iustin , Dumitrascu Anda , Goldstein Andrei , Poiana Catalina

Background: Growth hormone directly stimulates tumour growth, angiogenesis and metastasis through autocrine and paracrine effects on cancer cells, while through IGF1 inhibits apoptosis and promotes epithelial proliferation. Although disputed, some studies have shown an increased cancer incidence in acromegaly patients, especially in uncontrolled subjects, while others have not.Aim: To assess prevalence of cancer in a cohort of patients with long term tre...

ea0086p259 | Neuroendocrinology and Pituitary | SFEBES2022

Successful use of recombinant human TSH prior to radioiodine therapy in an acromegaly patient with differentiated thyroid cancer and pituitary insufficiency

Toma Iustin , Trifanescu Raluca , Goldstein Andrei , Dumitrascu Anda , Poiana Catalina

Background: Differentiated thyroid cancer (DTC) is the most common endocrine malignancy. Standard treatment includes thyroidectomy (extention depending on tumour size, pathology and lymph nodes involvement). If indicated, radioiodine therapy after TSH stimulation either by levothyroxine withdrawal or rhTSH administration is recommended. In patients with thyrotropin deficiency rhTSH administration is mandatory.Case report: A 30-year-old woman, resident in...

ea0063p1102 | Pituitary and Neuroendocrinology 3 | ECE2019

The significance of low TSH value – case report

Vlad Mihaela , Amzar Daniela , Sotanga Lavinia , Toma Andreea

Introduction: Suppression of TSH usually indicates hyperthyroidism. But the etiology of low TSH is very wide, including pituitary pathology. In this report we describe a case diagnosed and treated for hyperthyroidism. Later on, the persistence of suppressed TSH after therapy of hyperthyroidism was due to a GH-secreting pituitary adenoma.Case presentation: A 47-year old woman was referred to our clinic for investigations, due to thyroid pathology. The pat...

ea0035p307 | Clinical case reports Thyroid/Others | ECE2014

Challenges in exophthalmia management: Frontal mucocele

Toma Nicoleta , Mocanu Bogdan , Daniela Alexandrescu , Badiu Corin

Frequently seen in connection with thyroid disease, exophtalmic syndrome has a much large spectrum of differential diagnosis including numerous local and general aetiologies. Conditions such as mucoceles of paranasal sinuses don’t have always nasal or sinus symptoms but may present with ophthalmological manifestations.A 50-year-old woman presented for a 2-months history of right eye proptosis with upper eyelid swelling, periorbital pain, occasionall...

ea0092ps3-25-08 | Case Reports 2 | ETA2023

Resistance to thyroid hormone in the absence of thyroid hormone receptor mutation: A case report

Jesenko Miha , Kocjan Tomaž , Krhin Blaž , Gaberscek Simona

Introduction: Resistance to thyroid hormone beta is a genetic disease defined by impaired sensitivity of target tissue to thyroid hormone caused by mutation of thyroid hormone receptor beta gene, appearing with an incidence of 1/40,000. The characteristic biochemical profile of resistance to thyroid hormone is elevated serum thyroid hormone level and inappropriate serum level of thyrotropin (TSH) which is normal or elevated. Clinical picture is variable ranging from asymptomat...

ea0099p244 | Adrenal and Cardiovascular Endocrinology | ECE2024

Cardiovascular risk in patients with primary hyperparathyroidism

Trifanescu Raluca , Mohora Maria , Toma Iustin , Nitu Ileana , Poiana Catalina

Background: PTH is a hormone with vascular and cardiovascular properties, involved in the expression of endothelial pro-atherosclerotic and pro-inflammatory parameters. Both hypercalcemic and normocalcemic primary hyperparathyroidism (PHPT) were associated with increased cardiovascular risk.Patients and methods: 84 patients (6M/78F) with PHPT, aged 58.9±12.7 years, were retrospectively reviewed. Serum calcium levels, PTH and 25 OH vitamin D levels w...

ea0099p540 | Pituitary and Neuroendocrinology | ECE2024

Pituitary apoplexy – a tertiary centre experience

Rakusa Matej , Bošnjak Roman , Kocjan Tomaž

Background: Pituitary apoplexy (PA) is a rare, potentially life-threatening endocrine emergency, due to abrupt pituitary haemorrhage and/or infarction, usually within a pituitary adenoma. PA most commonly presents with severe headache, visual and oculomotor activity disturbances, nausea/vomiting and/or altered mental status. The outcome is variable and difficult to predict. Most proposed risk factors are hypertension (HTN), diabetes mellitus (DM), and anticoagulant treatment. ...

ea0081rc2.4 | Rapid Communications 2: Adrenal and Cardiovascular Endocrinology 1 | ECE2022

Diagnostic value of basal cortisol level to predict adrenal insufficiency in patients treated with glucocorticoids during COVID-19: a single centre observational cohort study

Jensterle Mojca , Rakusa Matej , Vidmar Gaj , Janez Andrej , Kocjan Tomaž

Objective: During the current pandemic of COVID-19, many therapeutic protocols adopted high dose systemic glucocorticoids (GC) for treatment of moderate to severe respiratory insufficiency. The suppression of the hypothalamic–pituitary–adrenal axis by synthetic GC, even after a short treatment period, cannot be reliably predicted due to pathophysiological changes in cortisol dynamics in critically ill, inter-individual pharmacokinetic differences, and sensitivity var...

ea0081ep208 | Calcium and Bone | ECE2022

Patient with mediastinal mass and hypercalcemia

Mlekus Kozamernik Katarina , Salobir Barbara , Hočevar Marko , Kocjan Tomaž

Introduction: Hypercalcemia is mostly caused by primary hyperparathyroidism and malignancy. Parathyromatosis is a rare condition characterized by multiple nodules of hyperfunctioning parathyroid tissue scattered throughout the neck and superior mediastinum, which can present a diagnostic and therapeutic challenge.Case report: A 56-year-old woman visited the ER due to chest pain, left-sided neck edema, and hematoma. The day before, she experienced left-si...